Use of Lidocaine in Endoscopic Submucosal Dissection
The primary purpose of this study is to investigate the effects of lidocaine on the total administered dose of fentanyl during sedation for endoscopic mucosal resection.

The secondary purpose of this study is to investigate the effects of lidocaine on pain score related with endoscopic mucosal resection at time of 30 min, 6 hr, and 24 hr after procedure.
Gastric Neoplasm
DRUG: Lidocaine 1%|DRUG: Normal saline
Fentanyl consumption during sedation, During sedation, an expected average of 40 minutes
Pain intensity measured by numerical rating scale, 0 = no pain at all and 10 = worst pain imaginable (11-point numerical rating scale), 30 min, 6 hr, and 24 hr after procedure|Incidence of nausea and vomiting, Nausea requiring antiemetics and retching and/or vomiting, Up to 24 hours
The primary purpose of this study is to investigate the effects of lidocaine on the total administered dose of fentanyl during sedation for endoscopic mucosal resection.

The secondary purpose of this study is to investigate the effects of lidocaine on pain score related with endoscopic mucosal resection at time of 30 min, 6 hr, and 24 hr after procedure.